Success rate in the treatment of congenital nasolacrimal duct obstructio
Not Applicable
- Conditions
- Congenital obstruction of the nasolacrimal duct.Neonatal obstruction of nasolacrimal ductH04.53
- Registration Number
- IRCT20220120053771N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 164
Inclusion Criteria
pure type of congenital nasolacrimal duct obstruction,
Age under 5 years,
negative fluorosin test without underlying disease or other syndromic disorder,
without previous history of nasolacrimal duct intervention or manipulation.
Exclusion Criteria
Patient / parent dissatisfaction with the study,
uncontrollable infection,
underlying disease or limitation of anesthesia,
concomitant tumors or bleeding disorders,
concomitant disorders of facial ossification,
cleft palate (even (Secretly),
developmental disorders or defects,
problems related to the pituitary gland or Ratke sinus and other abnormalities of the midline of the face.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of success rate in modified surgical intervention methods with probing method with turbine fracture and Crawford implantation in the treatment of congenital nasolacrimal duct obstruction. Timepoint: patients will be examined for the success of the intervention as well as the complications of the interventionm, a day after the intervention,. At 3 months and 6 months after the surgery, patients will be re-evaluated for the visual system and fluorocin test will be performed, and the results of follow-up and examination at times 0, 3 and 6 (months) will be evaluated and compared. Method of measurement: At each follow-up, patients will undergo a complete evaluation of the visual system and perform a fluorescein test.
- Secondary Outcome Measures
Name Time Method